Physician profile
Laura Inger
NPI 1275833162
$1,641.88
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $242 · 2020: $858 · 2021: $332 · 2022: $53.89 · 2024: $155.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $155.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $155.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $415.54 | 2020-2021 | |
| Biotissue Holdings INC. | $156.43 | 2019-2022 | |
| Abbvie INC. | $138.57 | 2022-2024 | |
| Novartis Pharmaceuticals Corporation | $133.08 | 2019-2021 | |
| Johnson & Johnson Vision Care, INC. | $131.00 | 2020-2021 | |
| Aerie Pharmaceuticals, INC. | $125.23 | 2019-2021 | |
| Allergan, INC. | $108.24 | 2020-2021 | |
| Kala Pharmaceuticals, INC. | $105.60 | 2020-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $102.16 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $45.90 | 2019-2021 | |
| Coopervision INC. | $37.32 | 2020 | |
| Sight Sciences, INC. | $34.95 | 2020-2021 | |
| Amgen INC. | $25.07 | 2024 | Tepezza |
| Visioneering Technologies, INC. | $17.79 | 2020 | |
| Ocular Therapeutix, INC. | $17.39 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $16.41 | 2019 | |
| Rxsight INC | $15.86 | 2024 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge, Rxsight Injector Handpiece |
| Abb Con-Cise Optical Group LLC | $15.34 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Inger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.